Deck
The world's second-largest spirits group — Absolut, Jameson, Martell, Chivas Regal, Havana Club — selling premium spirits across more than 160 countries and earning through brand pricing power and premiumisation rather than volume growth.
The price fell far more than the business did, and most of the gap is a lower multiple.
- The gap, in money: about $40B of enterprise value was removed, of which roughly $34B — seven-eighths — is the lower multiple rather than lost earnings, set against a conservative $1.1–3.4B present value for the disclosed shock.
- The contingency: the gap rewards a buyer only if the re-rating is wrong — that is, only if the demand behind the lost pricing proves cyclical rather than a structural reset. EBITDA fell about 10%; recurring EPS is down about 37% to the FY2026 trough and estimates are still being cut.
- The strongest fact against: part of the price/mix reversal is mechanical — Martell's −8 points track the December-2024 loss of China Duty Free, its highest-price channel, which reopened in Q3 FY2026 with double-digit Martell Chinese New Year sell-out, so some negative mix should reverse whatever underlying demand does.
The case is most sensitive to whether the demand decline is cyclical or a structural reset.
- Volume held; pricing broke: group volumes returned to +4% in Q3 FY2026, but Strategic International Brands price/mix swung from +11 points in FY2023 to −5 in FY2025 and −4 in H1 FY2026 — the premiumisation that carried a decade of earnings turned into a drag.
- Industry-wide, not company-specific: Diageo, Brown-Forman and Rémy Cointreau all show the same volume-up, price/mix-down signature; US spirits value fell 2.2% in 2025 while volume rose 1.9%, and super-premium-plus fell about 15% — category downtrading, not Pernod execution.
- A real structural overlay: moderation, Gen-Z abstinence and GLP-1 sit behind the price, against the company's own case that spirits keep taking share and penetration is rising; management cut its medium-term algorithm from +4–7% to +3–6%. The read is cyclical on volume, open on price/mix.
The cash case is real but below the framework's reference lines, and buybacks stopped at the lows.
The classic dislocation drives the free-cash-flow yield past 10% because cash holds while the price falls; here the numerator fell too — reported free cash flow of $1.3B is down from $1.9B in FY2022. The $5.52 dividend, frozen since FY2023, now absorbs about 65% of recurring profit against a ~50% policy and is uncovered on reported cash. Liquidity is deep and there is no financial covenant, so the balance sheet buys time — but the buyback that would compound a contrarian's edge stopped near the lows.
The damage concentrated in the highest-margin region; the growth engine sits in India.
- The epicenter: Asia and rest-of-world is 42% of sales but 46% of recurring profit, and it fell hardest — Martell cognac volumes dropped from 2.4M to 1.9M cases and China sales fell 21% in FY2025, hit by weak demand and a duty-free suspension at once.
- The trade shock resolved: China's anti-dumping ruling in July 2025 set five-year duties but exempted Martell and 33 other houses via minimum-price undertakings, and China Duty Free cognac reopened in Q3 FY2026 with double-digit Martell Chinese New Year sell-out.
- India offsets growth before profit: India grew every year through the downturn (+6% FY2025, +11% Q3 FY2026) on roughly 25M new legal-drinking-age adults a year — but it is lower-margin than the cognac profit it must replace, and carries Maharashtra excise and legal risk.
The promotional-CEO screen does not fit, and the wider brand book held its volume.
- Family control, aligned: the Ricard concert holds 15.1% of capital and 21.9% of votes; Alexandre Ricard chairs and runs the group with a stake worth about $2.8B, roughly 440x his pay, and insiders and family were net buyers through the fall.
- The double edge: control removes any activist catalyst on an 18-month clock, while a patient owner is a feature on the 8-to-20-year clock; the record also shows missed buyback and leverage targets, so promise-versus-delivery is imperfect.
- Moat wide but uneven: Jameson volumes rose every year, from 10.4M to 11.2M cases, and Chivas and Beefeater kept positive pricing; the damage clustered in Martell and prestige Scotch, while Absolut turned negative on price for the first time — the vodka soft spot where the structural question is most live.
At $73.13 the price implies almost no future growth; the upside turns on the demand decline proving cyclical.
Where it trades: Pernod Ricard is the cheapest large spirits name — about 8x EV/EBITDA on roughly double any peer's yield — sitting near what a permanently lower earning-power outcome is worth. An illustrative scenario ladder runs from about $60 (structural impairment) to about $132 (full cyclical recovery); the price sits near the structural-base rung, and the consensus median target is $101, about +39%.
The bull and bear share the same facts: the multiple has already compressed to a level that survives a no-growth outcome, so the downside is bounded unless earning power falls further or the dividend is cut; against that, price/mix — the mechanism that carried earnings for a decade — is still negative, and a valuation cheap on trailing earnings looks ordinary on a permanently lower base.
What this is: a guided study built chapter by chapter for this company, and a briefing rather than a call — the structural-demand question will not be settled inside an 18-to-24-month clock, and that limit is stated rather than hidden.
Watchlist to re-rate: Price/mix inflection back toward positive (the reading is most sensitive to this line); China and US organic turning up from −7% and −12% in Q3 FY2026; and the FY2026/FY2027 dividend decision — $5.52 held versus a cut toward the ~$4.27 policy line.